(Q42987944)

12 November 2017

title

Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated cryptogenic chronic active hepatitis (English)

1 reference

12 November 2017

1 reference

A J Czaja

1

1 reference

12 November 2017

H F Taswell

series ordinal

2

1 reference

12 November 2017

J Rakela

series ordinal

3

1 reference

12 November 2017

C M Schimek

series ordinal

4

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 October 1990

1 reference

12 November 2017

1 reference

12 November 2017

volume

65

1 reference

12 November 2017

issue

10

1 reference

12 November 2017

page(s)

1303-1313

1 reference

Subdivisions of idiopathic autoimmune chronic active hepatitis

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Etiology of sporadic hepatitis B surface antigen-negative hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Clinical, Epidemiological and Prognostic Aspects of Hepatitis “Non-A, Non-B”—a Comparison with Hepatitis A and B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Hepatitis C virus antibodies among risk groups in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Type 2 autoimmune hepatitis and hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

A classification of chronic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

The Chronic Sequelae of Non-A, Non-B Hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Autoimmune chronic active hepatitis developing after acute type B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Persistent measles virus genome in autoimmune chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Drug-induced chronic liver disease, with emphasis on chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Detection of antibodies directed against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Immunological Aspects of Chronic Active Hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2962141-7

10.1016/S0025-6196(12)62141-7

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference